A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.

NATerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 23, 2017

Primary Completion Date

January 9, 2018

Study Completion Date

January 9, 2018

Conditions

Migraine

Interventions

DEVICE

Relievion Device- Treatment Stimulation

1 Hour self-administered treatment specific occipital and supraorbital transcutaneous nerve stimulation

DEVICE

Relievion Device- Sham stimulation

1 Hour self-administered sham occipital and supraorbital transcutaneous nerve stimulation

Trial Locations (1)

Meir General Hospital, Kfar Saba